JAN 05, 2016 3:13 PM PST

Prevent Ebola From Mutating, Prevent It From Returning

WRITTEN BY: Kara Marker
There’s no rest for the weary, and that includes researchers looking for a definitive cure and treatment plan for Ebola patients. Even though Guinea was declared free of the hemorrhagic disease just before ringing in the new year, the threat of the virus evolving to be more dangerous and evasive than before has kept scientists on the hunt for a final answer.

Ebola is caused by an RNA virus whose genome encodes proteins such as nucleoprotein, glycoprotein, and L protein that are all sealed in a viral envelope (Kenyon College). Although there currently are vaccines that target these vital structural proteins to prevent Ebola virus from infecting host cells, a few different strains of the deadly disease exist that vary enough in amino acid and nucleotide sequencing to make a general vaccine impossible to create.

To make matters worse, the Ebola virus also contains to potential to evolve, and this is what scientists from the Texas Biomedical Research Institute wanted to investigate in a new Journal of Virology publication.
 

 
"Any change in a genome can be neutral, negative, or positive to a virus," Anthony Griffiths, PhD, explained. "Interestingly, viruses appear to have evolved to have an optimal mutation rate. Increasing the mutation rate could produce a negative effect on the virus and serve as a valuable therapeutic tool."

Griffiths explained that they will not have to prevent Ebola from mutating all together, just stimulate enough stress to increase the mutation rate so viral cells are weakened and inviable.

"We found that Ebola virus had very limited ability to tolerate spontaneous changes in the genome,” he said.

They tested a drug for chronic hepatitis C, called ribavirin, to see if Ebola cells faltered like they predicted they would after meddling with the viral mutation rate. Ribavirin is a nucleoside inhibitor that prevents viruses from synthesizing RNA and viral mRNA capping (Merck). Although the team saw successful clinical trials in mice and monkey subjects, further studies are required to make ribavirin a substantial candidate for treating Ebola.
 
The fight against Ebola in Guinea

Source: Texas Biomedical Research Institute
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 11, 2020
Cell & Molecular Biology
How Variants Affect Gene Expression Across Cell Types
SEP 11, 2020
How Variants Affect Gene Expression Across Cell Types
The Genotype-Tissue Expression (GTEx) Consortium, has produced multiple papers that have provided new insight into human ...
OCT 05, 2020
Immunology
Can't Shed Those Extra Pounds? An Inflammatory Gene Could Be to Blame.
OCT 05, 2020
Can't Shed Those Extra Pounds? An Inflammatory Gene Could Be to Blame.
  Australian scientists have zeroed in on a gene linked to an increased obesity risk: a regulator of inflammation c ...
OCT 12, 2020
Genetics & Genomics
The Malaria Parasite Can Change Host Cell Genetics
OCT 12, 2020
The Malaria Parasite Can Change Host Cell Genetics
Mosquitoes can transmit the malaria-causing Plasmodium parasite to humans. Malaria was estimated to have caused the deat ...
NOV 12, 2020
Cardiology
Creating a Mouse Model to Test RBM20 Dependent Dilated Cardiomyopathy
NOV 12, 2020
Creating a Mouse Model to Test RBM20 Dependent Dilated Cardiomyopathy
Cardiovascular disease is something that, in most cases, is within our ability to control. A healthy diet and active lif ...
NOV 17, 2020
Genetics & Genomics
Why Mutations in RRP7 Cause a Congenital Brain Disorder
NOV 17, 2020
Why Mutations in RRP7 Cause a Congenital Brain Disorder
A large family with some members that have a rare brain disorder has helped scientists learn more about both brain devel ...
NOV 20, 2020
Genetics & Genomics
How a Genetic Mutation Can be Good for Carriers
NOV 20, 2020
How a Genetic Mutation Can be Good for Carriers
Genetic mutations are usually connected to disease, but there are some that are known to improve people's lives.
Loading Comments...